Leadership: Page 23

PharmaVoice Team/PharmaVoice

Thought Leaders

Ryan Abbate. President, Pacific Communications, a healthcare communications agency that offers strategic and tactical communications solutions. For more information, visit pacific-com.com. Edward Abrahams, Ph.D. President,The Personalized Medicine Coalition, which brings together the academ...
By PharmaVoice Team • March 7, 2011
PharmaVoice Team/PharmaVoice

Millennials: Problems or Prodigies?

Our experts say, however, this is a generation worth catering to, because if they are happy, they will most certainly succeed. Getting all four generations to work together effectively is challenging because the generations have difficulty relating to one another as they interact in the workplace...
By PharmaVoice Team • Dec. 27, 2010
Explore the Trendline➔

Stock via Getty Images

Trendline

Clinical trial diversity

As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.
By PharmaVoice staff
PharmaVoice Team/PharmaVoice

E-Media

New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: Tibco Unveils Solution for Accelerating Drug Development C3i Offers Subscription-Based Data Management Hosting Medidata Adds Supply Management, Source Document Verification Solutions Chiltern Solution Consolidates...
By PharmaVoice Team • Aug. 26, 2010
PharmaVoice Team/PharmaVoice

The CREATIVES

Let the Force be Creative These rock stars of healthcare advertising are infusing their creative passion and energy into healthcare communications across all media. There is no off switch for Jamie Cobb, Executive Creative Director at MicroMass Communications; he is always on, always thinking, a...
By PharmaVoice Team • July 28, 2010
PharmaVoice Team/PharmaVoice

The MARKETERS

The next big idea lies in pushing beyond comfort zones, and Dan Bobear fearlessly tackles issues head-on and challenges all who work with him to feed their minds to achieve marketing excellence. In leading his team at Palio, he breaks down the unpredictable and channels his colleagues’ energy a...
By PharmaVoice Team • July 28, 2010
PharmaVoice Team/PharmaVoice

Haiti: A Beacon of Hope Through the Rubble

The pharmaceutical and biotech industry is one built upon the foundations of human fragility. It is a business of identifying physiological weaknesses and developing the medicines and products to address those faults, thus resulting in an enhanced standard of living and optimum health for the hum...
By Kelly Markham • April 28, 2010
PharmaVoice Team/PharmaVoice

The New Washington Office

The legislative push for healthcare reform came with a speed and scope that surprised many in the pharmaceutical industry, drawing new attention to the Washington, D.C., offices of many drug companies. With this new attention comes the potential for new roles and responsibilities for Washington-b...
By Dennis R. Cryer • Jan. 26, 2010
PharmaVoice Team/PharmaVoice

PDUFA III

As time was about to expire, Congress approved legislation reauthorizing the Prescription Drug User Fee Act of 1992 (PDUFA) for five years. The reauthorization of PDUFA was included in the bioterrorism leg islation passed in May by both houses of Congress, and was signed into law by President Bus...
By PharmaVoice Team • Jan. 14, 2010
PharmaVoice Team/PharmaVoice

Thought-Full Relationships

In the drive for market success, top companies are harnessing and capitalizing on knowledge “owned” by specialists, often referred to as thought leaders. According to Best Practices Inc., Pfizer successfully employed thoughtleader endorsements by consulting the Vatican when releasing Viagra and l...
By PharmaVoice Team • Jan. 14, 2010
PharmaVoice Team/PharmaVoice

Talent Pool

Pharma POOL Margaret M.FORAN Chuck HARDWICK Pat KELLY Ian READ Pfizer Names Presidents for U.S., European Pharmaceuticals Businesses,Head of Corporate Affairs, and Corporate Secretary Pat Kelly and Ian Read have been appointed presidents responsible for the U.S. and European pharmaceuticals busin...
By PharmaVoice Team • Jan. 11, 2010
PharmaVoice Team/PharmaVoice

What's New

WHAT’S NEW NEW HEALTHCARE RELATED PRODUCTS, SERVICES, AND COMPANIES In response to the growing demand for quality patient education, two top ranked healthcare divisions of Vox Medica Inc. — CoMed Communications Inc., a strategic medical education and communications company, and Signova Inc.,a hea...
By PharmaVoice Team • Nov. 3, 2009
PharmaVoice Team/PharmaVoice

E-learning: A Virtual Classroom

Pharmaceutical companies are jumping on board the etrain as a way to better manage their internal learning initiatives The THE CLICK MAY NEVER REPLACE THE NO. 2 PENCIL, but elearning is becoming the teacher’s pet in terms of reach, content flexibility, access, and alleviating outofoffice downtime...
By PharmaVoice Team • Nov. 2, 2009
PharmaVoice Team/PharmaVoice

Sales Reps — What's Up Doc?

The relationship between the pharmaceutical sales representative and the physician has undergone a dramatic shift in recent years. In the past, the sales representative provided value to the physician, had an established and meaningful rela tionship, engaged in an interactive dialog, and acted as...
By PharmaVoice Team • Nov. 2, 2009
PharmaVoice Team/PharmaVoice

Creating Opportunity From Diversity

bring messages about their products to diverse groups in a way that is culturally sensitive, that will garner longterm goodwill of the communities, and that address the most press ing health concerns facing various racial and ethnic groups. Developing diverse marketing promotions and programs whe...
By PharmaVoice Team • Nov. 2, 2009
PharmaVoice Team/PharmaVoice

Planting the Seeds of a Blockbuster

Until fairly recently, top tier pharmaceutical companies obtained license rights to a product developed by a biotechnology company, thereby infusing much needed capital for furtherance of clinical research. In return, the pharmaceutical company obtained outright or major ity rights to marketing a...
By PharmaVoice Team • Oct. 23, 2009
PharmaVoice Team/PharmaVoice

Coming Into Focus

The pharmaceutical powerhouses have either been U.S. or European companies, and all have extensive operations in the U.S. Of the top 10 pharmaceutical companies, six are U.S.based companies, the remaining four have their headquarters either in the United Kingdom or continental Europe, according t...
By PharmaVoice Team • Oct. 23, 2009
PharmaVoice Team/PharmaVoice

Beyond the Genome — Proteomics

Drug discovery in the postgenomic era will lead researchers to focus on the proteins and biological mechanisms that cause disease as a way to develop new types of treatments that are safer and more effective BY DENISE MYSHKO When the initial map of the human genome was first published in February...
By PharmaVoice Team • Oct. 23, 2009
PharmaVoice Team/PharmaVoice

The Reputation Matrix

The pharmaceutical industry is in some respects the victim of its own success. In fact, some public relations experts believe that the industry suffers from cognitive dissonance. “Many people are not comfortable viewing an industry responsible for developing innovative medicines as being a profit...
By Denise Myshko • Sept. 28, 2009
PharmaVoice Team/PharmaVoice

A Publication Planning Update

Title VIII of FDAAA, which requires the posting of clinical trial data within one year from last patient last visit, puts the squeeze on publication planners to get study results published in a very tight time frame. The Title VIII section of the Food and Drug Administration Amendments Act (F...
By Robin Robinson • Sept. 28, 2009
PharmaVoice Team/PharmaVoice

Who's on the List by Section

The Commanders & Chiefs 12 Ahsan Awan Ross Bjella Laurie Cooke, R.Ph. John Farinacci Tuan Ha-Ngoc Fred Hassan Thomas Hughes, Ph.D. Greg Johnson Rick Keefer Kyle Kennedy William Maichle John Maraganore, Ph.D. Francois Nader, M.D. Nader Naeymi-Rad Angus Russell Laurent Schockmel, DVM Jeffrey St...
By PharmaVoice Team • July 30, 2009
PharmaVoice Team/PharmaVoice

The Reading List

NON-FICTION Memo to the President: How We Can Restore America’s Reputation and Leadership • Madeleine Albright Making it all Work: Winning at the Game of Work and the Business of Life • David Allen Who Goes First?: The Story of Self-Experimentation in Medicine • Lawrence K. Altman It’s Not About ...
By PharmaVoice Team • July 30, 2009
PharmaVoice Team/PharmaVoice

Predicting the Future The Business Case for Forecasting

By Kim Ribbink Risk is an inherent part of the pharmaceutical business — risk of failure in clinical trials, risk that a product won’t achieve regulatory approval, risk that a product underperforms in the market, and risk of withdrawal after adverse reactions and the costly lawsuits that can foll...
By PharmaVoice Team • March 25, 2009
PharmaVoice Team/PharmaVoice

UpFront

Investment Portfolio R&D Spending by U.S. Biopharmaceutical Companies Increases 3% in 2008 A new report reveals that R&D investment in new medicines by the biopharmaceutical industry was $65.2 billion in 2008, an increase of 3% from 2007, according to a combined analysis conducted by Burr...
By PharmaVoice Team • March 25, 2009
PharmaVoice Team/PharmaVoice

E-Media

NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES ePocrates To Collaborate With Express Scripts on HANDHELD FORMULARY INITIATIVE ePocrates has agreed to incorporate the formu lary information of Express Scripts Inc., a national pharmacy benefits manager, into the ePocrates Rx Form...
By PharmaVoice Team • March 11, 2009
PharmaVoice Team/PharmaVoice

PharmaOutlet

The hottest concept in pharmaceutical marketing and PR today — for that matter the hottest concept in all marketing today — is so old that it didn’t seem at all out of place when it turned up in a lyric in the biblical rock opera, Jesus Christ Superstar: “What’s the Buzz, tell us what’s a happeni...
By Robert Chandler and Gianfranco Chicco • March 10, 2009